17 | Interferon Type IIBA
05/2022
-
07/2006 |
17 | DNA (Deoxyribonucleic Acid)IBA
05/2022
-
01/2006 |
17 | Antiviral Agents (Antivirals)IBA
01/2020
-
08/2005 |
16 | CytokinesIBA
05/2022
-
01/2005 |
16 | Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
-
06/2004 |
12 | Pattern Recognition ReceptorsIBA
05/2022
-
02/2007 |
11 | Nucleic AcidsIBA
01/2022
-
01/2006 |
10 | Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2022
-
04/2006 |
10 | Proteins (Proteins, Gene)FDA Link
01/2019
-
05/2006 |
8 | RNA (Ribonucleic Acid)IBA
10/2021
-
05/2006 |
8 | InterferonsIBA
01/2019
-
06/2004 |
6 | Phosphotransferases (Kinase)IBA
02/2014
-
06/2004 |
5 | Pathogen-Associated Molecular Pattern MoleculesIBA
01/2021
-
02/2011 |
5 | Poly I-CIBA
01/2019
-
12/2008 |
5 | RNA Helicases (RNA Helicase)IBA
12/2012
-
10/2005 |
4 | Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
01/2018
-
04/2006 |
4 | Double-Stranded RNA (RNA, Double Stranded)IBA
07/2011
-
06/2004 |
3 | LipopolysaccharidesIBA
07/2022
-
06/2004 |
3 | InflammasomesIBA
01/2021
-
11/2008 |
3 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2014
-
11/2010 |
3 | Small Interfering RNA (siRNA)IBA
05/2011
-
10/2005 |
3 | NF-kappa B (NF-kB)IBA
12/2008
-
01/2005 |
2 | Topotecan (Hycamtin)FDA LinkGeneric
01/2022
-
01/2017 |
2 | NucleotidesIBA
01/2022
-
04/2009 |
2 | 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022
-
01/2017 |
2 | cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2022
-
01/2019 |
2 | Dextrans (Dextran)FDA Link
01/2021
-
11/2008 |
2 | phosphatidylinositol 5-phosphateIBA
01/2019
-
08/2013 |
2 | Peptide Hydrolases (Proteases)FDA Link
02/2014
-
09/2013 |
2 | Transcription Factors (Transcription Factor)IBA
08/2013
-
04/2006 |
2 | Lysine (L-Lysine)FDA Link
06/2012
-
11/2010 |
2 | Toll-Like Receptor 7IBA
06/2012
-
03/2011 |
2 | NLR ProteinsIBA
05/2011
-
02/2011 |
2 | ChemokinesIBA
02/2011
-
08/2009 |
2 | hemozoinIBA
01/2007
-
01/2005 |
1 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2022 |
1 | Toll-Like Receptor 4IBA
07/2022 |
1 | Topoisomerase I InhibitorsIBA
01/2022 |
1 | Biomarkers (Surrogate Marker)IBA
10/2021 |
1 | Interferon Regulatory FactorsIBA
01/2021 |
1 | Anti-Allergic Agents (Antiallergic Agents)IBA
01/2021 |
1 | sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021 |
1 | InterleukinsIBA
01/2021 |
1 | 1'-acetoxychavicol acetateIBA
01/2021 |
1 | Interleukin-17 (Interleukin 17)IBA
01/2021 |
1 | Antimicrobial PeptidesIBA
01/2021 |
1 | Vaccine AdjuvantsIBA
01/2021 |
1 | Interleukin-33IBA
10/2020 |
1 | Detergents (Detergent)IBA
10/2020 |
1 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019 |
1 | Protein Tyrosine PhosphatasesIBA
01/2019 |
1 | Poly dA-dT (dT, Poly dA)IBA
01/2019 |
1 | Protein Kinases (Protein Kinase)IBA
01/2019 |
1 | myotubularinIBA
01/2019 |
1 | Phosphatidylinositols (Phosphatidylinositol)IBA
01/2019 |
1 | phosphatidylinositol 3-phosphateIBA
01/2019 |
1 | Adenosine Monophosphate (AMP)IBA
01/2017 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2017 |
1 | Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2017 |
1 | bis(3',5')-cyclic diguanylic acidIBA
01/2017 |
1 | bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2017 |
1 | Messenger RNA (mRNA)IBA
04/2014 |
1 | Z-Form DNA (Z-DNA)IBA
02/2014 |
1 | Carrier Proteins (Binding Protein)IBA
02/2014 |
1 | VaccinesIBA
09/2013 |
1 | Pharmaceutical PreparationsIBA
09/2013 |
1 | LipidsIBA
08/2013 |
1 | Fas Ligand Protein (Fas Ligand)IBA
01/2013 |
1 | Viral RNAIBA
12/2012 |
1 | LigandsIBA
06/2012 |
1 | Interferon-gamma (Interferon, gamma)IBA
06/2012 |
1 | CXC ChemokinesIBA
06/2012 |